We have uncovered brand new blockbuster evidence that shows us that the Natural Health Trends (NASDAQ:NHTC) Chinese regulatory investigation is now happening on a national level, and not just at the company’s satellite Beijing offices. We think this may confirm the […]
We’re accumulating shares of this restaurant stock, which we believe could double, based on a robust fiscal 2015 growth outlook and opportunities from the company’s capital deployment plan to shareholders. We are also encouraged by strong same store sales numbers from […]
Strong EPS growth in estimated EPS for 2015 and 2016 has lead us to begin our initial due diligence on both Everyday Health Inc. (NYSE:EVDY) and Cal-Maine Foods Inc. (NASDAQ:CALM). Strong EPS Growth in Analyst Estimates on EVDY and CALM Can Not Be […]
GeoTeam Divulges Long Speculative Bet on China Fruits Corp (CHFR) China Fruits Corp (CHFR) ($0.14) is a distributor and producer of fresh tangerine and other fresh fruits in the People’s Republic of China. We are Long CHFR, but know this is very […]
Anyone following Herbalife Ltd. (HLF), Nu Skin Enterprises Inc. (NUS) and USANA Health Sciences Inc. (USNA) , know that the debate over the practices of multi-level marketing (“MLM”), particularly with U.S. companies operating in China, has been a hot topic. […]
Thermal Tennis Inc (OTCCB:TTNS) – CannaSys was originally organized as a Colorado limited liability company in October 2013 and converted to a Colorado corporation in June 2014. Based on their experience for over four years in the medical cannabis dispensary […]
Sciclone Pharmaceuticals (NASDAQ:SCLN)($6.79) – and its partner BTG plc (LSE: BTG), today announced, that the China Food and Drug Administration has approved the registration of DC Bead for the embolization of malignant hypervascularized tumors. BTG and SciClone previously entered into […]
A commercial-stage specialty pharmaceutical company, develops and commercializes supportive care products. INSY announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to its pharmaceutical cannabidiol (CBD) for the treatment of glioblastoma multiforme (GBM), the […]